These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 36856182)
1. Identification of a copper metabolism-related gene signature for predicting prognosis and immune response in glioma. Li L; Leng W; Chen J; Li S; Lei B; Zhang H; Zhao H Cancer Med; 2023 Apr; 12(8):10123-10137. PubMed ID: 36856182 [TBL] [Abstract][Full Text] [Related]
2. A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients. Xiang Z; Chen X; Lv Q; Peng X Front Genet; 2021; 12():697819. PubMed ID: 34408772 [TBL] [Abstract][Full Text] [Related]
3. The study of an anoikis-related signature to predict glioma prognosis and immune infiltration. Zhang D; Wang Y; Zhou H; Han X; Hou L; Lv Z; Xue X J Cancer Res Clin Oncol; 2023 Nov; 149(14):12659-12676. PubMed ID: 37450027 [TBL] [Abstract][Full Text] [Related]
4. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
5. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy. Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X Front Immunol; 2022; 13():899710. PubMed ID: 35677036 [TBL] [Abstract][Full Text] [Related]
6. Analysis of cuproptosis-related genes in prognosis and immune infiltration in grade 4 diffuse gliomas. Liu H; Bao X; Zeng Z; Liu W; Li M Heliyon; 2024 Apr; 10(7):e29212. PubMed ID: 38633656 [TBL] [Abstract][Full Text] [Related]
7. A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy. Zeng Z; Hu C; Ruan W; Zhang J; Lei S; Yang Y; Peng P; Pan F; Chen T Front Immunol; 2022; 13():1001381. PubMed ID: 36159801 [TBL] [Abstract][Full Text] [Related]
8. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma. Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808 [No Abstract] [Full Text] [Related]
9. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis. Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q Front Genet; 2022; 13():1053263. PubMed ID: 36712869 [No Abstract] [Full Text] [Related]
10. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma. Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X Front Oncol; 2021; 11():682932. PubMed ID: 34123852 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma. Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z Cells; 2022 Dec; 11(24):. PubMed ID: 36552760 [TBL] [Abstract][Full Text] [Related]
12. Development of a copper metabolism-related gene signature in lung adenocarcinoma. Chang W; Li H; Zhong L; Zhu T; Chang Z; Ou W; Wang S Front Immunol; 2022; 13():1040668. PubMed ID: 36524120 [TBL] [Abstract][Full Text] [Related]
13. Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas. Luo C; Liu Z; Ye W; Liu F Front Cell Dev Biol; 2021; 9():756005. PubMed ID: 34805164 [No Abstract] [Full Text] [Related]
14. Integrative Analysis of Inflammatory Response-Related Gene for Predicting Prognosis and Immunotherapy in Glioma. Zhao Z; Zheng B; Zheng J; Zhang Y; Jiang C; Nie C; Jiang X; Yao D; Zhao H J Mol Neurosci; 2023 Aug; 73(7-8):608-627. PubMed ID: 37488455 [TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients. Hu Y; Tu Z; Lei K; Huang K; Zhu X Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238 [TBL] [Abstract][Full Text] [Related]
16. Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas. Huang W; Wu Y; Zhu J; Luo N; Wang C; Liu S; Cheng Z Front Mol Biosci; 2023; 10():963639. PubMed ID: 36825202 [TBL] [Abstract][Full Text] [Related]
17. Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas. Tang X; Guo D; Yang X; Chen R; Jiang Q; Zeng Z; Li Y; Li Z Cells; 2022 Nov; 11(22):. PubMed ID: 36429083 [No Abstract] [Full Text] [Related]
18. Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients. Yan Z; Gao Y; Yu J; Shen Z; Bu X J Immunol Res; 2022; 2022():8972730. PubMed ID: 35647198 [TBL] [Abstract][Full Text] [Related]
19. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma. Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q Front Immunol; 2022; 13():1011757. PubMed ID: 36325335 [TBL] [Abstract][Full Text] [Related]
20. Transcriptomic Characterization of Copper-Binding Proteins for Predicting Prognosis in Glioma. Zeng HL; Li H; Yang Q; Li CX Brain Sci; 2023 Oct; 13(10):. PubMed ID: 37891828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]